BIM
FLNA

BlackRock Investment Management’s Filana Therapeutics FLNA Stock Holding History

BlackRock Investment Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$4K Hold
958
– – ﹤0.01% 3803
2016
Q3 		$7K Hold
958
– – ﹤0.01% 3707
2016
Q2 		$15K Buy
958
+14
+1% +$222 ﹤0.01% 3462
2016
Q1 		$15K Hold
944
– – ﹤0.01% 3466
2015
Q4 		$12K Buy
944
+16
+2% +$212 ﹤0.01% 3613
2015
Q3 		$12K Hold
928
– – ﹤0.01% 3615
2015
Q2 		$11K Sell
928
-15,524
-94% -$213K ﹤0.01% 3684
2015
Q1 		$218K Buy
16,452
+712
+5% +$9.61K ﹤0.01% 3202
2014
Q4 		$224K Buy
15,740
+77
+0.5% +$1.33K ﹤0.01% 3242
2014
Q3 		$429K Buy
15,663
+540
+4% +$16.4K ﹤0.01% 3048
2014
Q2 		$609K Buy
+15,123
New +$560K ﹤0.01% 2931

Other funds holding FLNA

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
ZIM
Zacks Investment Management Chicago, Illinois $12.5B AUM 29.36% 1-Year Est. Return

BlackRock Investment Management's FLNA Position: Q4 2016 in Review

BlackRock Investment Management held its Filana Therapeutics (FLNA) position steady in Q4 2016 at 958 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #3803.

BlackRock Investment Management first reported a position in FLNA in Q2 2014 and has held it in 11 quarters since. The position peaked at $609K in Q2 2014. 46 funds tracked by Wall St. Rank hold FLNA as of Q4 2016.

  • BlackRock Investment Management held 958 shares of Filana Therapeutics worth $4K as of Q4 2016.
  • BlackRock Investment Management left its Filana Therapeutics share count unchanged in Q4 2016.
  • Filana Therapeutics made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3803 holding.
  • BlackRock Investment Management first reported a position in Filana Therapeutics in Q2 2014 and has held it in 11 quarters since.
  • BlackRock Investment Management's Filana Therapeutics position peaked at $609K in Q2 2014.
  • 46 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.